A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/403 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2493202
The use of an arylidene 2-indolinone derivative for treating tumors involving Met, PDGF-R, FGF-RI, FGF-R3 and Kit tyrosine kinases, or the oncoproteins of Ret family is disclosed. The invention also provides pharmaceutical compositions comprising laid arylidene 2-indolinone derivative as well as a kit comprising, in separate containers, said derivative and an anti-cancer or anti-tumor agent.
L'invention concerne l'utilisation d'un dérivé arylidène 2-indolinone pour le traitement de tumeurs impliquant des Met, des PDGF-R, des FGF-RI, des FGF-R3 et des Kit tyrosine kinases, ou les oncoprotéines de la famille Ret. L'invention concerne également des compositions pharmaceutiques comprenant ledit dérivé arylidène 2-indolinone, ainsi qu'une trousse comprenant, dans des contenants séparés, ledit dérivé et un agent anticancéreux ou antitumoral.
Cassinelli Giuliana
Cuccuru Giuditta
Lanzi Cinzia
Menta Ernesto
Pierotti Marco Alessandro
Cell Therapeutics Europe S.r.l.
Instituto Nazionale Per Lo Studio E. La Cura Dei Tumori
Kirby Eades Gale Baker
LandOfFree
Antitumor compound and therapeutic uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumor compound and therapeutic uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor compound and therapeutic uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2013342